Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1999 | 06-1999 | 03-1999 | 12-1998 | 09-1998 | |
| Sales | 509 | 577 | 1,592 | 360 | 700 |
| Cost of Goods | 410 | 340 | 470 | 360 | 500 |
| Gross Profit | 90 | 220 | 1,110 | 10 | 200 |
| Operating Expenses | 1,640 | 1,570 | 1,870 | 2,990 | 2,030 |
| Operating Income | -1,131 | -993 | -278 | -2,630 | -1,330 |
| Interest Expense | 0 | 10 | 0 | -1 | 0 |
| Other Income | 11 | 13 | 18 | 39 | 70 |
| Pre-tax Income | -1,120 | -990 | -260 | -2,590 | -1,260 |
| Net Income Continuous | -1,192 | -998 | -290 | -2,590 | -1,260 |
| Net Income | $-1,192 | $-998 | $-290 | $-2,590 | $-1,260 |
| EPS Basic Total Ops | -0.84 | -0.72 | -0.20 | N/A | N/A |
| EPS Basic Continuous Ops | -0.84 | -0.70 | -0.20 | N/A | N/A |
| EPS Diluted Total Ops | -0.84 | -0.72 | -0.20 | N/A | N/A |
| EPS Diluted Continuous Ops | -0.84 | -0.70 | -0.20 | N/A | N/A |
| EBITDA(a) | $-1,021 | $-903 | $-158 | $-2,370 | $-1,210 |